You have 9 free searches left this month | to do more

pemetrexed

Pemetrexed is a drug used to treat Non Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Mesothelioma, and other conditions. Pemetrexed is being actively studied in 190 studies and prior, has been studied in 213.

Top SponsorsTop SitesTop Investigators
Eli Lilly and CompanyFor additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.Si-Yu Wang
Merck Sharp & Dohme Corp.Research SiteZhenyu Pan
Hoffmann-La RocheAsan Medical CenterChang Jian Hua
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Active, not recruiting
  • Chordoma
  • Pemetrexed
  • Santa Monica, California
    John Wayne Cancer Institute
2022-03-08
Mar 8, 2022
H
Recruiting
  • Central Nervous System Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
2022-01-28
Jan 28, 2022
M
Terminated
  • Advanced Cancers
  • Crizotinib (Xalkori)
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-09-03
Sep 3, 2021
T
Recruiting
  • Leptomeningeal Metastases
  • Pemetrexed
  • +3 more
  • Changchun, Jilin, China
    The First Hospital of Jilin University
2022-03-17
Mar 17, 2022
U
Recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
2022-03-01
Mar 1, 2022
S
Completed
  • Lung Cancer
  • Nashville, Tennessee
    Tennessee Oncology
2022-02-21
Feb 21, 2022
A
Recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • Augusta, Georgia
    Augusta University Georgia Cancer Center
2022-03-06
Mar 6, 2022
S
Completed
  • Malignant Pleural Mesothelioma
  • Non-Small Cell Lung Cancer
  • Chiba, Japan
  • +1 more
2021-09-05
Sep 5, 2021
N
Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Augusta, Georgia
    Augusta University Georgia Cancer Center
2021-07-31
Jul 31, 2021
R
Recruiting
  • Non Small Cell Lung Cancer
  • Mesothelioma
  • Pemetrexed
  • 's-Hertogenbosch, Netherlands
  • +4 more
2021-09-14
Sep 14, 2021
R
Recruiting
  • Non Small Cell Lung Cancer
  • Mesothelioma
  • Pemetrexed
  • 's-Hertogenbosch, Netherlands
  • +4 more
2021-09-14
Sep 14, 2021
R
Recruiting
  • Non Small Cell Lung Cancer
  • Mesothelioma
  • Pemetrexed
  • 's-Hertogenbosch, Netherlands
  • +4 more
2021-09-14
Sep 14, 2021
M
Recruiting
  • Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-17
Nov 17, 2021
C
Completed
  • Non-small Cell Lung Cancer
  • Pemetrexed
  • Chalon-sur-Saône, France
  • +2 more
2021-05-21
May 21, 2021
N
Completed
  • Brain and Central Nervous System Tumors
  • +10 more
  • Pemetrexed
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
2021-09-03
Sep 3, 2021
T
Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
2022-03-01
Mar 1, 2022
X
Recruiting
  • Nonsquamous Non-Small Cell Lung Cancer
  • Yichang, Hubei, China
    Department of Medical Oncology, Central Hospital of Yichang City
2021-11-05
Nov 5, 2021
T
Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • Non-Small Cell Carcinoma of Lung, TNM Stage 4
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • +4 more
  • Boston, Massachusetts
    Tufts Medical Center
2022-01-05
Jan 5, 2022
N
Recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • Cancer, Lung
  • Nagoya, Aichi, Japan
    National Hospital Organization Nagoya Medical Center
2021-04-23
Apr 23, 2021
S
Recruiting
  • Non-small Cell Lung Cancer
  • Seoul, Gangnamgu, Korea, Republic of
    Samsung Medical Center
2021-12-27
Dec 27, 2021
J
Not yet recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • EGFR Activating Mutation
  • Urayasu, Chiba, Japan
  • +9 more
2022-02-17
Feb 17, 2022